No Data
Hangzhou Minsheng Healthcare (SZSE:301507) Will Want To Turn Around Its Return Trends
Minsheng Health (301507.SZ): The company and its wholly-owned subsidiary received a certificate for an invention patent.
On December 24, Gelonghui reported that Minsheng Health (301507.SZ) announced that recently, the company and its wholly-owned subsidiary Minsheng Zhongke Jiayi (Zhejiang) Biotechnology Co., Ltd. (formerly Zhejiang Minsheng Health Technology Co., Ltd.) received a certificate of invention patent issued by the National Intellectual Property Administration. The invention is titled "A method for extracting Vitamin K2 from a composite formulation of various Vitamins and Minerals," with a patent term of twenty years.
Hangzhou Minsheng Healthcare Co., Ltd.'s (SZSE:301507) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
People\'s Livelihood and Health: Report for the Third Quarter of 2024
Minsheng Health (301507.SZ): The net income in the first three quarters was 86.1784 million yuan, a year-on-year increase of 5.52%.
Gelonghui, October 28 - Minsheng Health (301507.SZ) released the third quarter report for 2024. In the first three quarters of 2024, the company achieved revenue of 0.52 billion yuan, a year-on-year increase of 6.98%; the net income attributable to the shareholders of the listed company was 86.1784 million yuan, a year-on-year increase of 5.52%; the net income after deducting non-recurring gains and losses was 82.3756 million yuan, a year-on-year increase of 9.30%; basic earnings per share were 0.24 yuan per share.
Hangzhou Minsheng Healthcare's (SZSE:301507) Returns On Capital Not Reflecting Well On The Business
